// App-Quantinova.ai

: Practical Adherence to AHA/ACC 2018 Guidelines Among Secondary Prevention Patients

Researchers

Presenter

  • Aleesha Kainat

Principal Investigators

  • Mohammad Ateya

  • Michael J Becich

  • Alison Bradley

  • David A Demicco

  • Soledad Fernandez

  • Dan Ford

  • Rozelle Hegeman-Dingle

  • Wenke Hwang

  • Jong Jeong

  • Martha O Jurczak

  • H Lester Kirchner

  • Euan McLeod

  • Kathleen M McTigue

  • Richard S Morgan

  • Anuradha Paranjape

  • Phillip Saccone

  • Neena Thomas

  • Kevin A Townsend

  • David A Williams

  • Jonathan Arnold

Medical Centers

  • Emergency Medicine, Univ of Pittsburgh, Pittsburgh, PA

  • UPMC Mckeesport, Mckeesport, PA

  • Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA

  • Pfizer Inc, New York, NY

  • North American Med Affairs, Pfizer, Inc, Ann Arbor, MI

  • Dept of Medicine, Univ of Michigan, Ann Arbor, MI

  • Global Med Affairs, Pfizer, Inc, New York, NY

  • Emergency Medicine, Univ of Pittsburgh, Pittsburgh, PA

  • North American Med Affairs, Pfizer, Inc, Ann Arbor, MI

  • Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA

  • Health Economics and Outcomes Rsch, Pfizer, Inc, Tadworth, United Kingdom

  • Dept of Internal Medicine, Temple Univ Hosp, Philadelphia, PA

  • Public Health Sciences, Penn State College of Medicine, Hershey, PA

  • Dept of Population Health Sciences, Geisinger, Danville, PA

  • Institute for Clinical and Translational Rsch, Johns Hopkins, Baltimore, MD

  • Department of Biomedical Informatics, The Ohio State University, Columbus, OH

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A